bronchiectasis
Conditions
Interventions
Experimental group:modified Cangma Decoction
Control group:oral liquid of Carbocysteine
Sponsors
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Eligibility
Sex/Gender
All
Age
19 Years to 79 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the above diagnosis of bronchiectasis and airway mucus hypersecretion; 2. Patients who meet the above diagnosis of spleen deficiency and phlegm dampness syndrome; 3. Older than 18 years and younger than 80 years; 4. The original score of casa-q expectoration symptom domain is greater than or equal to 4 points.
Exclusion criteria
Exclusion criteria: 1. Liver function ALT > 75 U/L, AST > 60 U/L, TBIL > 30.75 umol/l; renal function in patients with Cr > 15 mmol/L; 2. Complicated with serious cardiovascular and cerebrovascular complications and serious gastrointestinal diseases; 3. Patients with various organ tumors; 4. Pregnant and lactating women; 5. Patients with severe mental illness; 6. Known allergy to test drug; 7. Participated in other clinical trials within three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| score of CASA-Q; | — |
Secondary
| Measure | Time frame |
|---|---|
| number of acute exacerbations within 3 months;blood routine;c reactive protein; | — |
Countries
China
Contacts
Public ContactXitong Liu
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Outcome results
None listed